Cost-Effectiveness Analysis of Fourth- or Further-Line Ripretinib in Advanced Gastrointestinal Stromal Tumors

BACKGROUND: The INVICTUS trial assessed the efficacy and safety of ripretinib compared with placebo in the management of advanced gastrointestinal stromal tumors. METHOD: We used a Markov model with three health states: progression-free disease, progression disease and death. We parameterized the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Weiting, Xu, Huiqiong, Hutton, David, Wu, Qiuji, Zhou, Kexun, Luo, Hui, Lei, Wanting, Feng, Mingyang, Yang, Yang, Wen, Feng, Li, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685288/
https://www.ncbi.nlm.nih.gov/pubmed/34938653
http://dx.doi.org/10.3389/fonc.2021.692005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685288/
https://www.ncbi.nlm.nih.gov/pubmed/34938653
http://dx.doi.org/10.3389/fonc.2021.692005

Ejemplares similares